Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (5)
- (-) Composites (1)
- (-) Fusion (3)
- (-) Materials Science (11)
- (-) Security (2)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (6)
- Artificial Intelligence (2)
- Big Data (2)
- Bioenergy (4)
- Climate Change (1)
- Computer Science (9)
- Coronavirus (4)
- Cybersecurity (3)
- Decarbonization (1)
- Energy Storage (2)
- Environment (4)
- Grid (2)
- Isotopes (2)
- Machine Learning (2)
- Microscopy (2)
- Molten Salt (1)
- Nanotechnology (4)
- National Security (2)
- Neutron Science (31)
- Nuclear Energy (14)
- Physics (4)
- Quantum Science (3)
- Summit (5)
- Sustainable Energy (4)
- Transformational Challenge Reactor (2)
- Transportation (1)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
By automating the production of neptunium oxide-aluminum pellets, Oak Ridge National Laboratory scientists have eliminated a key bottleneck when producing plutonium-238 used by NASA to fuel deep space exploration.